Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Genmab (GMAB – Research Report) today and set a price target of $31.00. The ...
In a report released today, Emily Field from Barclays maintained a Buy rating on Genmab A/S (0MGB – Research Report), with a price target of ...
For Q4 2024, the Harding Loevner International Developed Markets Equity composite fell 8.4% (gross) behind the 7.4% decline ...
Harding Loevner International Equity ADR composite fell 7.9%, gross, behind the 7.5% decline of the MSCI ACWI ex US Index.
Spain 10 Year Government Bond-0.027 3.097% ...
IPC Indice de Precios Y Cotizaciones 54,077.94-82.17-0.15% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback